I.E.G. V. H.
- Country
- The Netherlands
- Department
- Oncology
Research Overview
- Phase III Multicenter Randomized Trial of Dose-Reduced Chemotherapy with Fluorouracil, Folinic Acid, Capecitabine, and Oxaliplatin in Metastatic Colorectal Cancer
- Evaluation of Nivolumab Efficacy in Active Surveillance Post-Neoadjuvant Chemoradiation for Esophageal Cancer: SANO-3 Study
- Phase 2 Randomized Study of Liposomal Irinotecan, Carboplatin, and Oxaliplatin in First-Line Treatment of Metastatic or Locally Advanced Esophagogastric Cancer
Data & Insights
Has run more than one trial at 29 of 65 partner sites.
Specializations
Gastrointestinal Oncology
This investigator specializes in the treatment of esophageal cancer, with particular focus on innovative therapeutic approaches in gastrointestinal oncology.
- Advanced esophageal cancer management
- Neoadjuvant therapy approaches
- Chemoradiation protocols
The investigator explores treatment strategies involving both conventional and emerging therapeutic modalities.
Immunotherapy Research
Focused on implementing immunotherapy treatments in gastrointestinal cancers, particularly exploring the role of immune checkpoint inhibitors.
- Novel immunotherapy applications
- Treatment response monitoring
- Patient surveillance protocols
The investigator evaluates innovative approaches in immunotherapy for gastrointestinal malignancies.
Active Surveillance Studies
Specializes in developing and implementing active surveillance protocols for patients who have undergone cancer treatment.
- Post-treatment monitoring strategies
- Response assessment methods
- Patient outcome evaluation
The investigator focuses on optimizing surveillance strategies in oncology care.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.